Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Debt to Equity: 2018-2020

  • Neurocrine Biosciences' Debt to Equity was N/A to $0.53 in Q3 2020 from the same period last year, while for Dec 2019 it was $0.64, marking a year-over-year change of. This contributed to the annual value of $0.64 for FY2019, which is N/A change from last year.
  • According to the latest figures from Q3 2020, Neurocrine Biosciences' Debt to Equity is $0.53, which was up 4.70% from $0.50 recorded in Q2 2020.
  • Neurocrine Biosciences' Debt to Equity's 5-year high stood at $0.86 during Q3 2018, with a 5-year trough of $0.50 in Q2 2020.
  • In the last 3 years, Neurocrine Biosciences' Debt to Equity had a median value of $0.59 in 2020 and averaged $0.63.